Whereas sorting for CD8+CD39+ T cells also enriched for tumour-reactive T cells, in 4 out of 4 patients, at least one of the cluster-derived T cell groups outperformed them in tumour cell killing (Fig. 4i and Extended Data Fig. 9e). The gene discussed is CD8A; the disease is neoplasm.